Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratinocyte desmosome disruption refers to the process by which alpha hydroxy acids (AHAs) weaken the adhesive structures (desmosomes/corneodesmosomes) between keratinocytes in the epidermis. This disruption is primarily achieved through chelation of calcium ions necessary for desmosomal cadherin function and modulation of intracellular calcium levels, leading to increased cell turnover and exfoliation. This process is targeted by AHAs for cosmetic and therapeutic applications such as chemical peels, acne treatment, and anti-aging.
Chelation of calcium ions from desmosomal cadherins, leading to disruption of cell-cell adhesion; Intracellular acidification and TRPV3 activation, promoting apoptosis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratinocyte Desmosome Disruption.